A detailed history of Proficio Capital Partners LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Proficio Capital Partners LLC holds 667 shares of VRTX stock, worth $334,647. This represents 0.03% of its overall portfolio holdings.

Number of Shares
667
Previous 846 21.16%
Holding current value
$334,647
Previous $396,000 21.72%
% of portfolio
0.03%
Previous 0.04%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$460.0 - $505.78 $82,340 - $90,534
-179 Reduced 21.16%
667 $310,000
Q2 2024

Jul 25, 2024

BUY
$392.81 - $485.53 $9,034 - $11,167
23 Added 2.79%
846 $396,000
Q1 2024

May 02, 2024

BUY
$407.69 - $446.08 $13,861 - $15,166
34 Added 4.31%
823 $344,000
Q4 2023

Feb 13, 2024

SELL
$343.0 - $410.68 $1,372 - $1,642
-4 Reduced 0.5%
789 $321,000
Q3 2023

Oct 18, 2023

BUY
$338.18 - $362.46 $24,687 - $26,459
73 Added 10.14%
793 $275,000
Q2 2023

Aug 14, 2023

BUY
$314.42 - $351.91 $10,061 - $11,261
32 Added 4.65%
720 $253,000
Q1 2023

Apr 21, 2023

SELL
$283.23 - $323.1 $61.2 Million - $69.8 Million
-216,080 Reduced 99.68%
688 $216,000
Q1 2023

Apr 19, 2023

BUY
$283.23 - $323.1 $61.4 Million - $70 Million
216,768 New
216,768 $68.3 Million
Q4 2020

Feb 11, 2021

SELL
$207.01 - $276.09 $156,706 - $209,000
-757 Closed
0 $0
Q3 2020

Nov 02, 2020

BUY
$255.65 - $303.1 $5,624 - $6,668
22 Added 2.99%
757 $206,000
Q2 2020

Aug 14, 2020

BUY
$225.48 - $295.8 $165,727 - $217,413
735 New
735 $213,000
Q3 2019

Nov 13, 2019

SELL
$166.23 - $187.09 $55,354 - $62,300
-333 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$164.61 - $190.37 $2,304 - $2,665
14 Added 4.39%
333 $61,000
Q1 2019

May 13, 2019

BUY
$163.73 - $194.7 $10,806 - $12,850
66 Added 26.09%
319 $59,000
Q4 2018

Feb 08, 2019

SELL
$151.91 - $192.21 $759 - $961
-5 Reduced 1.94%
253 $42,000
Q3 2018

Nov 13, 2018

BUY
$167.73 - $192.74 $1,341 - $1,541
8 Added 3.2%
258 $50,000
Q2 2018

Aug 10, 2018

BUY
$145.72 - $169.96 $1,457 - $1,699
10 Added 4.17%
250 $42,000
Q1 2018

May 14, 2018

SELL
$151.6 - $177.13 $1,212 - $1,417
-8 Reduced 3.23%
240 $39,000
Q4 2017

Feb 09, 2018

SELL
$137.28 - $155.55 $7,138 - $8,088
-52 Reduced 17.33%
248 $37,000
Q3 2017

Nov 14, 2017

BUY
$148.13 - $162.24 $44,439 - $48,672
300
300 $46,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Proficio Capital Partners LLC Portfolio

Follow Proficio Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Proficio Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Proficio Capital Partners LLC with notifications on news.